SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-13-000042
Filing Date
2013-06-04
Accepted
2013-06-04 18:34:31
Documents
1
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 8225
  Complete submission text file 0000885590-13-000042.txt   9834
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VALEANT PHARMACEUTICALS INTERNATIONAL 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5
Business Address
Hall Susan (Reporting) CIK: 0001542052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 13892707